07Mar 2023
Hydroxychloroquine to prevent SARS-CoV-2 infection among healthcare workers: early termination of a phase 3, randomised, open-label, controlled clinical trial

Hydroxychloroquine to prevent SARS-CoV-2 infection among healthcare workers: early termination of a phase 3, randomised, open-label, controlled clinical trial

The study aimed to evaluate the effectiveness and safety of hydroxychloroquine (HCQ) prophylaxis for preventing SARS-CoV-2 infection in healthcare workers (HCW) during the COVID-19 pandemic. The study randomly allocated 68 HCWs to receive HCQ or not. The results showed no significant difference in the incidence of SARS-CoV-2 infections between both study arms, and there were no serious adverse events. However, poor participant accrual led to low statistical power, and two participants withdrew consent due to adverse events.

  • #family health

Like

Save

Share